Beta-blocker therapy and angina burden after myocardial infarction: A prespecified substudy of the BETAMI-DANBLOCK trial
Primary result · Angina-related hospital contact/diagnostic ischemia testResult — go to the resultSubdistribution hazard ratio 0.85 95% CI 0.77–0.94Authors' conclusion
In patients with MI and LVEF≥40%, a moderate dose of beta-blockers was associated with a lower incidence of first angina-related hospital contact/diagnostic ischemia testing, and lower use of calcium-channel blockers. The absence of differences in coronary revascularization, nitrate use and patient-reported angina symptoms suggests that the overall benefit on angina is limited.
Study context
- Population
- Patients with myocardial infarction (MI) and left ventricular ejection fraction (LVEF)≥40%
- Participants
- 5,574 patients
- Comparison
- Beta-blockers vs no beta-blockers
- Beta-blocker groupn = 2,783
- No beta-blocker groupn = 2,791
Methodological detailsrandomized
- Randomized
Primary result
As reported in the abstract
Angina-related hospital contact/diagnostic ischemia test · median 3.5 years follow-up
Beta-blocker groupvs No beta-blocker group
SHR 0.85 (95% CI 0.77–0.94)
Further findings
| Outcome | SHR (95% CI) | |
|---|---|---|
| Coronary revascularization | 0.99 (0.76–1.29) | |
| 0.512Subdistribution hazard ratio (log scale) |
| Outcome | Beta-blocker group | No beta-blocker group | Difference in proportions (percentage points) (95% CI) | |
|---|---|---|---|---|
| Calcium-channel blocker treatmentFewer with beta-blockers | 22.7% | 26.6% | −3.9 (−6.2 to −1.6) | |
| −10−505Difference, percentage points (linear scale) |
| Outcome | Beta-blocker group | No beta-blocker group | Estimate | |
|---|---|---|---|---|
| Nitrate useSimilar between groups | 12.3% | 12.8% | difference in proportions −0.5 (95% CI −2.2 to 1.2) | |
| CCS-score · 12-monthsSimilar between groups | difference in change −0.04 (95% CI −0.14 to 0.05) | |||
| −3−2−1012Difference (linear scale) |
Coronary revascularization
- Coronary revascularization occurred in 108 (3.9%) vs. 110 patients (3.9%)
Original publication
Beta-blocker therapy and angina burden after myocardial infarction: A prespecified substudy of the BETAMI-DANBLOCK trial. Eur Heart J Cardiovasc Pharmacother. Published 13 November 2026. doi:10. 1093/ ehjcvp/ pvag097
Composed by AI from the published abstract and checked against it. How Briefs are made →